BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31364411)

  • 1. Pharyngo-laryngeal involvement in systemic amyloidosis with cardiac involvement: a prospective observational study.
    Bartier S; Bodez D; Kharoubi M; Canouï-Poitrine F; Chatelin V; Henrion C; Coste A; Damy T; Béquignon E
    Amyloid; 2019 Dec; 26(4):216-224. PubMed ID: 31364411
    [No Abstract]   [Full Text] [Related]  

  • 2. Rare Forms of Cardiac Amyloidosis: Diagnostic Clues and Phenotype in Apo AI and AIV Amyloidosis.
    Ioannou A; Porcari A; Patel RK; Razvi Y; Sinigiani G; Martinez-Naharro A; Venneri L; Moon J; Rauf MU; Lachmann H; Wechelakar A; Hawkins PN; Gillmore JD; Fontana M
    Circ Cardiovasc Imaging; 2023 Jul; 16(7):523-535. PubMed ID: 37431665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between hearing loss and hereditary ATTR amyloidosis.
    Bartier S; Bodez D; Kharoubi M; Guellich A; Canouï-Poitrine F; Chatelin V; Coste A; Damy T; Béquignon E
    Amyloid; 2019 Dec; 26(4):234-242. PubMed ID: 31502881
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis.
    Louwsma J; Brunger AF; Bijzet J; Kroesen BJ; Roeloffzen WWH; Bischof A; Kuhle J; Drost G; Lange F; Kuks JBM; Gans ROB; Hazenberg BPC; Nienhuis HLA
    Amyloid; 2021 Mar; 28(1):50-55. PubMed ID: 32883119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS.
    Caponetti AG; Rapezzi C; Gagliardi C; Milandri A; Dispenzieri A; Kristen AV; Wixner J; Maurer MS; Garcia-Pavia P; Tournev I; Planté-Bordeneuve V; Chapman D; Amass L;
    JACC Heart Fail; 2021 Oct; 9(10):736-746. PubMed ID: 34391735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of swallowing disorders in patients with dysphonia.
    Krasnodębska P; Szkiełkowska A; Jarzyńska-Bućko A; Włodarczyk E; Miaśkiewicz B
    Otolaryngol Pol; 2019 Sep; 74(2):17-22. PubMed ID: 32022701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis.
    Kharoubi M; Bézard M; Galat A; Le Bras F; Poullot E; Molinier-Frenkel V; Fanen P; Funalot B; Moktefi A; Lefaucheur JP; Abulizi M; Deux JF; Lemonnier F; Guendouz S; Chalard C; Zaroui A; Audard V; Bequignon E; Bodez D; Itti E; Hittinger L; Audureau E; Teiger E; Oghina S; Damy T
    ESC Heart Fail; 2021 Dec; 8(6):5501-5512. PubMed ID: 34714605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How your ears can tell what is hidden in your heart: wild-type transthyretin amyloidosis as potential cause of sensorineural hearing loss inelderly-AmyloDEAFNESS pilot study.
    Béquignon E; Guellich A; Bartier S; Raynal M; Prulière-Escabasse V; Canouï-Poitrine F; Coste A; Damy T
    Amyloid; 2017 Jun; 24(2):96-100. PubMed ID: 28598686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
    Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
    Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac amyloidosis-interdisciplinary approach to diagnosis and therapy.
    Hänselmann A; Berliner D; Bauersachs J; Bavendiek U
    Herz; 2022 Aug; 47(4):324-331. PubMed ID: 35674775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis.
    Brownrigg J; Lorenzini M; Lumley M; Elliott P
    ESC Heart Fail; 2019 Oct; 6(5):1041-1051. PubMed ID: 31487121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features and impact of dysphagia, dysphonia and laryngeal hypersensitivity in whiplash associated disorder - a qualitative study.
    Stone DB; Rebbeck T; Ward EC; Elliott JE
    Disabil Rehabil; 2023 Jul; 45(15):2446-2457. PubMed ID: 35867954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac amyloidosis is associated with increased aortic stiffness.
    Nemes A; Földeák D; Domsik P; Kalapos A; Kormányos Á; Borbényi Z; Forster T
    J Clin Ultrasound; 2018 Mar; 46(3):183-187. PubMed ID: 29064094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Dysphagia in Patients With Non-neoplastic Vocal Fold Pathology.
    Hamdan AL; Khalifee E; Jaffal H; Ghanem A; Rizk SA; El Hage A
    J Voice; 2019 Sep; 33(5):708-711. PubMed ID: 29884508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the prevalence and onset of dysphonia and dysphagia symptoms in movement disorders at an academic medical center.
    Finger ME; Madden LL; Haq IU; McLouth CJ; Siddiqui MS
    J Clin Neurosci; 2019 Jun; 64():111-115. PubMed ID: 30948311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysphonia and dysphagia after anterior cervical decompression.
    Tervonen H; Niemelä M; Lauri ER; Back L; Juvas A; Räsänen P; Roine RP; Sintonen H; Salmi T; Vilkman SE; Aaltonen LM
    J Neurosurg Spine; 2007 Aug; 7(2):124-30. PubMed ID: 17688050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of heart failure in transthyretin vs. light chain amyloidosis.
    Binder C; Duca F; Stelzer PD; Nitsche C; Rettl R; Aschauer S; Kammerlander AA; Binder T; Agis H; Kain R; Hengstenberg C; Mascherbauer J; Bonderman D
    Eur Heart J Cardiovasc Imaging; 2019 May; 20(5):512-524. PubMed ID: 30649240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
    Gentile L; Diemberger I; Plante-Bordeneuve V; Mazzeo A; Dori A; Luigetti M; Di Paolantonio A; Dispenzieri A; Grogan M; Waddington Cruz M; Adams D; Inamo J; Kristen AV; Lino Cirami C; Chapman D; Gupta P; Glass O; Amass L
    PLoS One; 2024; 19(1):e0292435. PubMed ID: 38241252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS).
    Barroso FA; Coelho T; Dispenzieri A; Conceição I; Waddington-Cruz M; Wixner J; Maurer MS; Rapezzi C; Planté-Bordeneuve V; Kristen AV; González-Duarte A; Chapman D; Stewart M; Amass L;
    Amyloid; 2022 Sep; 29(3):175-183. PubMed ID: 35451899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.